Deep TMS (Transcranial Magnetic Stimulation) Systems

Founded in 2003, with offices in the US and Israel, we are committed to increasing global awareness of and broad access to Deep TMS.

We are a global leader in advanced non-invasive neurostimulation treatment for mental health disorders and neurological illness using our proprietary Deep Transcranial Magnetic Stimulation platform technology to improve health and transform lives.

We are the first and only TMS company to obtain four FDA approvals (Depression, OCD, Smoking addiction, Anxious Depression) backed by pivotal studies demonstrating clinically proven efficacy.

Potential Business Partners: Distributors or agents with experience in the fields of psychiatry, neurology and rehabilitation.

Target Countries: Worldwide.

Company Info:
Year of Establishment:  2003
No.   of Employees:       110